Clinical trial
Effects of Goal-directed Fluid Therapy and Restrictive Fluid Therapy During Operation Combined With Enhanced Recovery After Surgery Protocol on Acute Kidney Injury After Thoracoscopic Lobectomy in High Risk Patients
NCT04302467 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Goal-directed Fluid Therapy and Restrictive Fluid Therapy During Operation Combined With Enhanced Recovery After Surgery Protocol on Acute Kidney Injury After Thoracoscopic Lobectomy in High Risk Patients
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- August 31, 2022
- Enrollment
- 276 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.